Adding to the list of larger news outlets covering what APC is up to is Endpoints News (from the Fin...
Pharmaceutical Technology lets us tell ’em how we really feel about Novo asking the FDA to put semag...
APC CEO Scott Brunner was a guest on “On The Pen” — a YouTube channel dedicated to all things GLP-1....
Getting away from GLP-1s, Pharmaceutical Executive features CEO Scott Brunner and Chief Advocacy Off...
Reuters, like many other media outlets, covered Novo Nordisk’s request that the FDA add semaglutide ...
A different angle: CBS News quoted Scott on the issue of how the FDA decides when a shortage is reso...
UK-based pharmaphorum is covering the GLP-1 issue on this side of the pond — specifically Lilly’s an...
The Hill covers the fallout from the FDA’s taking tirzepatide off the shortage list — especially how...
Specialty Pharmacy Continuum has a great piece explaining why a longer “tail” for 503A pharmacies wo...
Wired wrote about “The Crackdown on Compounded GLP-1 Meds,” where it made clear that it doesn’t quit...